Loading...
Please wait, while we are loading the content...
Quantitative autoradiographic mapping of opioid receptors in the brain of δ-opioid receptor gene knockout mice
| Content Provider | Semantic Scholar |
|---|---|
| Author | Goody, Robin J. Oakley, Sarah M. Filliol, Dominique Kieffer, Brigitte Lina Kitchen, I. |
| Copyright Year | 2002 |
| Abstract | Using quantitative receptor autoradiography we have determined if deletion of the delta-opioid receptor gene (Oprd1) results in compensatory changes in the expression of other opioid receptors. Gene targeting was used to delete exon 1 of the mouse delta-opioid receptor gene and autoradiography was carried out on brains from wild-type, heterozygous and homozygous knockout mice. Delta-opioid receptors were labeled with [(3)H]deltorphin I (7 nM), mu- with [(3)H]DAMGO (4 nM), and kappa- with [(3)H]CI-977 (2.5 nM) or [(3)H]bremazocine (2 nM in the presence of DPDPE and DAMGO) and non-specific binding determined with naloxone. [(3)H]Deltorphin I binding was reduced by approximately 50% in heterozygous animals. In homozygous animals specific binding could only be detected after long-term film exposure (12 weeks). Regions exhibiting this residual [(3)H]deltorphin I binding correlated significantly with those demonstrating high levels of the mu-receptor and were abolished in the presence of the mu-agonist DAMGO. Autoradiographic mapping showed significant overall reductions in [(3)H]DAMGO and [(3)H]CI-977 binding throughout the brain following loss of both copies of the Oprd1 gene. In contrast, overall levels of [(3)H]bremazocine binding were higher in brains from -/- than +/+ mice. Our findings suggest that residual [(3)H]deltorphin I binding in the brain of delta-receptor gene knockout mice is the result of cross-reactivity with mu-sites and that there are no delta-receptor subtypes derived from a different gene. Changes in mu- and kappa-receptor labeling suggest compensatory changes in these subtypes in response to the absence of the delta-receptor. The differences in [(3)H]CI-977 and [(3)H]bremazocine binding indicate these ligands show differential recognition of the kappa-receptor. |
| Starting Page | 9 |
| Ending Page | 19 |
| Page Count | 11 |
| File Format | PDF HTM / HTML |
| DOI | 10.1016/S0006-8993(02)02452-6 |
| PubMed reference number | 12113946 |
| Journal | Medline |
| Volume Number | 945 |
| Alternate Webpage(s) | https://api.elsevier.com/content/article/pii/S0006899302024526 |
| Alternate Webpage(s) | https://www.sciencedirect.com/science/article/pii/S0006899302024526?dgcid=api_sd_search-api-endpoint |
| Alternate Webpage(s) | https://doi.org/10.1016/S0006-8993%2802%2902452-6 |
| Journal | Brain Research |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |